Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Huot

Showing results (71-80 of 107) with videos related to

Pageof 11
Sort By:
Experimental Brain Research|October 10, 2018
Effect of the selective 5-HT<sub>2A</sub> receptor antagonist EMD-281,014 on L-DOPA-induced abnormal involuntary movements in the 6-OHDA-lesioned ratImane Frouni, Cynthia Kwan, Dominique Bédard, et al.
Parkinsonism & Related Disorders|August 21, 2012
RGFP109, a histone deacetylase inhibitor attenuates L-DOPA-induced dyskinesia in the MPTP-lesioned marmoset: a proof-of-concept studyTom H Johnston, Philippe Huot, Sammie Damude, et al.
The European Journal of Neuroscience|January 4, 2013
Use of catechol-O-methyltransferase inhibition to minimize L-3,4-dihydroxyphenylalanine-induced dyskinesia in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaquePhilippe Huot, Tom H Johnston, Tessa Snoeren, et al.
RMD Open|January 21, 2020
Early non-response to certolizumab pegol in rheumatoid arthritis predicts failure to achieve low disease activity at 1 year: data from a prospective observational studyAlain Saraux, René-Marc Flipo, Francis Fagnani, et al.
Journal of the Neurological Sciences|September 2, 2020
Neurological complications of coronavirus infection; a comparative review and lessons learned during the COVID-19 pandemicMaryam Sharifian-Dorche, Philippe Huot, Michael Osherov, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|January 4, 2021
Effect of the mGlu<sub>2</sub> positive allosteric modulator CBiPES on dyskinesia, psychosis-like behaviours and parkinsonism in the MPTP-lesioned marmosetImane Frouni, Cynthia Kwan, Stephen G Nuara, et al.
Behavioural Pharmacology|October 12, 2014
L-745,870 reduces the expression of abnormal involuntary movements in the 6-OHDA-lesioned ratPhilippe Huot, Tom H Johnston, James B Koprich, et al.
Neuroscience Research|December 26, 2021
Autoradiographic labelling of 5-HT<sub>3</sub> receptors in the hemi-parkinsonian rat brainCynthia Kwan, Catherine Lévesque, Dominique Bédard, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|June 20, 2024
Effect of mGluR<sub>2</sub> and mGluR<sub>2/3</sub> activators on parkinsonism in the MPTP-lesioned non-human primateImane Frouni, Cynthia Kwan, Dominique Bédard, et al.
Plos One|October 3, 2012
The monoamine re-uptake inhibitor UWA-101 improves motor fluctuations in the MPTP-lesioned common marmosetPhilippe Huot, Tom H Johnston, Michael N Gandy, et al.
Pageof 11

Showing results (71-80 of 107) with videos related to

Sort By:
Pageof 11
Experimental Brain Research|October 10, 2018
Effect of the selective 5-HT<sub>2A</sub> receptor antagonist EMD-281,014 on L-DOPA-induced abnormal involuntary movements in the 6-OHDA-lesioned ratImane Frouni, Cynthia Kwan, Dominique Bédard, et al.
Parkinsonism & Related Disorders|August 21, 2012
RGFP109, a histone deacetylase inhibitor attenuates L-DOPA-induced dyskinesia in the MPTP-lesioned marmoset: a proof-of-concept studyTom H Johnston, Philippe Huot, Sammie Damude, et al.
The European Journal of Neuroscience|January 4, 2013
Use of catechol-O-methyltransferase inhibition to minimize L-3,4-dihydroxyphenylalanine-induced dyskinesia in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaquePhilippe Huot, Tom H Johnston, Tessa Snoeren, et al.
RMD Open|January 21, 2020
Early non-response to certolizumab pegol in rheumatoid arthritis predicts failure to achieve low disease activity at 1 year: data from a prospective observational studyAlain Saraux, René-Marc Flipo, Francis Fagnani, et al.
Journal of the Neurological Sciences|September 2, 2020
Neurological complications of coronavirus infection; a comparative review and lessons learned during the COVID-19 pandemicMaryam Sharifian-Dorche, Philippe Huot, Michael Osherov, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|January 4, 2021
Effect of the mGlu<sub>2</sub> positive allosteric modulator CBiPES on dyskinesia, psychosis-like behaviours and parkinsonism in the MPTP-lesioned marmosetImane Frouni, Cynthia Kwan, Stephen G Nuara, et al.
Behavioural Pharmacology|October 12, 2014
L-745,870 reduces the expression of abnormal involuntary movements in the 6-OHDA-lesioned ratPhilippe Huot, Tom H Johnston, James B Koprich, et al.
Neuroscience Research|December 26, 2021
Autoradiographic labelling of 5-HT<sub>3</sub> receptors in the hemi-parkinsonian rat brainCynthia Kwan, Catherine Lévesque, Dominique Bédard, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|June 20, 2024
Effect of mGluR<sub>2</sub> and mGluR<sub>2/3</sub> activators on parkinsonism in the MPTP-lesioned non-human primateImane Frouni, Cynthia Kwan, Dominique Bédard, et al.
Plos One|October 3, 2012
The monoamine re-uptake inhibitor UWA-101 improves motor fluctuations in the MPTP-lesioned common marmosetPhilippe Huot, Tom H Johnston, Michael N Gandy, et al.
Pageof 11